Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease

by Adam, D., Avolio, J., Bartlett, C., Bégin, S., Berthiaume, Y., Bilodeau, L., Bjornson, C., Brochiero, E., Brusky, J., Chilvers, M., Côté-Maurais, G., Esmaeili, M., Gong, J., Gonska, T., Halevy, A., He, G., Hughes, D., Keenan, K., Leung, W.M, Lin, F., Mastromatteo, S., Mateos-Corral, D., Moraes, T.J, Morrison, N., Panjwani, N., Parkins, M., Price, A., Quon, B.S, Ratjen, F., Reisman, J., Rommens, J.M, Shaw, M., Smith, M.J, Solomon, M., Stephenson, A.L, Strug, L.J, Sun, L., Tullis, E., van Wylick, R., Wang, C., Wilcox, P.
Published 2022